This ASX 200 stock just dropped 20%. One expert just bought it

Here's your chance to buy the dip on a quality company that's created wealth for many investors for decades.

| More on:
ventilator mask

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Reporting season can be a hairy experience for many S&P/ASX 200 Index (ASX: XJO) stocks.

The market will react instantly to the contents of the annual report, triggering some violent movements in the share price.

One longtime favourite in the ASX 200 has copped precisely this treatment, with its valuation plummeting this month.

But one expert has taken advantage of the short-term fear to buy more of this quality business.

Let's take a look:

Market unimpressed with shrinking margins

Resmed CDI (ASX: RMD) has made many ASX investors wealthy over the past couple of decades with its rapid growth and dominance in a massive market.

However, the crowd did not like the look of its annual results released earlier this month.

ResMed's share price fell 10% within minutes, and it's been a 19.8% loss all up since the morning of 3 August.

Created with Highcharts 11.4.3ResMed PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.com.au

The 2023 financial year earnings per share (EPS) for the sleep apnoea devices maker fell 9 cents short of expectations.

"One disappointment that could be weighing on the ResMed share price was the company's margin performance," said The Motley Fool's James Mickleboro. 

"Analysts at Macquarie were expecting improvements in the fourth quarter, but the very opposite happened. ResMed's gross margin contract was 200 basis points for the three months, which dragged its full-year gross margin down 80 basis points to 55.8%."

ResMed management blamed the underperformance on higher input costs.

She'll be apples though

The great news for long-term investors is that this dip could be a golden buying opportunity.

Shaw and Partners portfolio manager James Gerrish certainly thought so, revealing his team had added to its existing holding.

"We stepped up and increased our weighting to 5%, believing the selling is overdone," Gerrish said on a Market Matters Q&A.

"After falling towards $27 we have indeed elected to increase our position in RMD… with the view that current margin issues can be overcome."

The other qualitative factor that seems to be worrying investors is the impact of current weight loss fads such as Ozempic.

The logic goes that if people lose weight then it decreases their chances of experiencing sleep apnoea, and therefore the demand for ResMed's machines plunges.

Gerrish thinks this isn't yet a huge influence on ResMed's actual fortunes.

"At this stage, the concerns [seem] overinflated.

"However, if the [drug] funding situation changes, and greater reimbursements are offered, this could become more material."

Many other professionals agree with Gerrish's bullishness.

According to CMC Markets, an overwhelming 19 out of 25 analysts still rate ResMed as a buy.

Motley Fool contributor Tony Yoo has positions in ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Fallers

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why Cromwell Property, Metcash, Pilbara Minerals, and Tyro shares are falling today

Let's see why these shares are under pressure on Tuesday.

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Block, Computershare, South32, and Strickland Metals shares are falling today

These shares are starting the week in the red. But why?

Read more »

Person with thumbs down and a red sad face poster covering the face.
Share Fallers

Why Imricor, Ora Banda, Ventia, and Vulcan shares are dropping today

These shares are ending the week in the red. But why?

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why CSL, Imricor, Jumbo, and Netwealth shares are falling today

These shares are under pressure on Thursday. But why?

Read more »

A man holds his head in his hands, despairing at the bad result he's reading on his computer.
Share Fallers

Guess which ASX 200 stock is crashing 42% on big news

Big bad news is weighing heavily on this stock today.

Read more »

A young woman holds an open book over her head with a round mouthed expression as if to say oops as she looks at her computer screen in a home office setting with a plant on the desk and shelves of books in the background.
Share Fallers

Why Beetaloo, Botanix, Cobram Estate, and Origin Energy shares are falling today

These shares are having a poor session on Tuesday. But why?

Read more »

Bored man sitting at his desk with his laptop.
Share Fallers

Why Antipa Minerals, Northern Star, Pilbara Minerals, and Synlait Milk shares are falling today

These shares are starting the week in the red. But why?

Read more »

a man weraing a suit sits nervously at his laptop computer biting into his clenched hand with nerves, and perhaps fear.
Share Fallers

Why Evolution Mining, G8 Education, Lottery Corp, and Lynas shares are tumbling today

These shares are ending the week in the red. But why?

Read more »